Ubs Asset Management Americas Inc Wave Life Sciences Ltd. Transaction History

Ubs Asset Management Americas Inc

  • $379 Billion
  • Q1 2025

A detailed history of Ubs Asset Management Americas Inc transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 183,402 shares of WVE stock, worth $1.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
183,402
Previous 165,238 10.99%
Holding current value
$1.1 Million
Previous $2.04 Million 27.51%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 19, 2025
BUY
$8.08 - $13.51 $146,765 - $245,395
18,164 Added 10.99%
183,402 $1.48 Million
Q4 2024

Feb 14, 2025
BUY
$8.0 - $16.44 $164,160 - $337,348
20,520 Added 14.18%
165,238 $2.04 Million
Q3 2024

Nov 14, 2024
SELL
$5.12 - $9.01 $134,814 - $237,242
-26,331 Reduced 15.39%
144,718 $1.19 Million
Q2 2024

Aug 13, 2024
BUY
$4.38 - $6.48 $420,462 - $622,054
95,996 Added 127.9%
171,049 $853,000
Q1 2024

May 15, 2024
BUY
$3.54 - $6.84 $63,815 - $123,304
18,027 Added 31.61%
75,053 $463,000
Q4 2023

Feb 14, 2024
BUY
$4.16 - $6.87 $237,228 - $391,768
57,026 New
57,026 $287,000
Q2 2021

Aug 16, 2021
SELL
$5.65 - $7.47 $127,718 - $168,859
-22,605 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$5.61 - $12.01 $68,139 - $145,873
-12,146 Reduced 34.95%
22,605 $126,000
Q4 2020

Mar 01, 2021
BUY
$6.99 - $9.26 $61,952 - $82,071
8,863 Added 34.24%
34,751 $273,000
Q3 2020

Nov 13, 2020
BUY
$8.49 - $19.54 $22,040 - $50,725
2,596 Added 11.15%
25,888 $219,000
Q2 2020

Aug 14, 2020
BUY
$7.44 - $11.29 $173,292 - $262,966
23,292 New
23,292 $242,000
Q3 2019

Nov 14, 2019
SELL
$19.17 - $27.4 $163,079 - $233,091
-8,507 Closed
0 $0
Q2 2019

Aug 15, 2019
SELL
$22.93 - $42.84 $3.08 Million - $5.75 Million
-134,301 Reduced 94.04%
8,507 $0
Q1 2019

May 14, 2019
BUY
$32.69 - $47.91 $153,871 - $225,512
4,707 Added 3.41%
142,808 $0
Q4 2018

Feb 13, 2019
SELL
$37.1 - $50.11 $456,997 - $617,254
-12,318 Reduced 8.19%
138,101 $5.81 Million
Q3 2018

Nov 14, 2018
BUY
$36.35 - $55.2 $199,088 - $302,330
5,477 Added 3.78%
150,419 $0
Q2 2018

Aug 14, 2018
BUY
$33.85 - $50.65 $4.91 Million - $7.34 Million
144,942 New
144,942 $0

Others Institutions Holding WVE

# of Institutions
205
Shares Held
125M
Call Options Held
499K
Put Options Held
180K
View Full List

About Wave Life Sciences Ltd.

WVE Quotes by TradingView
  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $522M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email